Your browser doesn't support javascript.
loading
Reversible splenial lesion syndrome in Anti-N-methyl-D-aspartate receptor encephalitis.
Wei, Rong; Mu, Xiaohua; Zhou, Li.
Afiliação
  • Wei R; Department of Neurology, Weifang People's Hospital, 151GuangWen Street, Weifang, 261000, Shandong, China.
  • Mu X; Department of Neurology, Weifang People's Hospital, 151GuangWen Street, Weifang, 261000, Shandong, China.
  • Zhou L; Department of Neurology, Weifang People's Hospital, 151GuangWen Street, Weifang, 261000, Shandong, China. zhouli_Neurology3@126.com.
Neurol Sci ; 45(9): 4639-4641, 2024 Sep.
Article em En | MEDLINE | ID: mdl-38949742
ABSTRACT
Here we described an 18-year-old woman who were initially misdiagnosed as psychiatric disorders in a psychiatric institution. She was transferred to our neurological ward because of impaired consciousness. Neuronal antibody testing confirmed the diagnosis of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Cerebral magnetic resonance imaging (MRI) revealed a concomitant disorder named reversible splenial lesion syndrome (RESLES). After administration of combined immunotherapy, the patient recovered completely 3 months after discharge. To our knowledge, co-occurrence of RESLES and anti-NMDAR encephalitis was only described in two patients with teratoma and we provide another case without teratoma. We highlight that anti-NMDAR antibodies can be added to the multiple causes of RESLES. It is therefore imperative for clinicians to detect anti-neuronal antibodies in patients with RESLES to avoid missed diagnosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalite Antirreceptor de N-Metil-D-Aspartato Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalite Antirreceptor de N-Metil-D-Aspartato Idioma: En Ano de publicação: 2024 Tipo de documento: Article